These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10942740)

  • 1. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators.
    Gillis AM; Connolly SJ; Lacombe P; Philippon F; Dubuc M; Kerr CR; Yee R; Rose MS; Newman D; Kavanagh KM; Gardner MJ; Kus T; Wyse DG
    Circulation; 2000 Aug; 102(7):736-41. PubMed ID: 10942740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: rationale and study design.
    Gillis AM
    Europace; 1999 Jan; 1(1):40-2. PubMed ID: 11220538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of pacing mode after interruption of atrioventricular conduction for atrial fibrillation: observations from the PA3 clinical trial.
    Gillis AM;
    Card Electrophysiol Rev; 2003 Dec; 7(4):312-4. PubMed ID: 15071244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of fixed rate versus rate responsive pacing after radiofrequency atrioventricular junction ablation: quality of life, ventricular refractoriness, and paced QT dispersion.
    Duff HJ; Raj SR; Exner DV; Sheldon RS; Roach D; Mitchell LB; Wyse DG; Morck M; Gillis AM
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1163-70. PubMed ID: 14678128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm.
    Marshall HJ; Harris ZI; Griffith MJ; Holder RL; Gammage MD
    Circulation; 1999 Mar; 99(12):1587-92. PubMed ID: 10096935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDD(R) pacing with automatic mode switch in patients with paroxysmal atrial fibrillation following AV nodal ablation.
    Schuchert A; van Langen H; Michels K; Meinertz T
    Cardiology; 1997; 88(4):323-7. PubMed ID: 9197425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.
    Brignole M; Gianfranchi L; Menozzi C; Alboni P; Musso G; Bongiorni MG; Gasparini M; Raviele A; Lolli G; Paparella N; Acquarone S
    Circulation; 1997 Oct; 96(8):2617-24. PubMed ID: 9355902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study.
    Petrac D; Radić B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):922-8. PubMed ID: 16342345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation.
    Hsieh MH; Tai CT; Lee SH; Tsao HM; Lin YK; Huang JL; Chan P; Chen YJ; Kuo JY; Tuan TC; Hsu TL; Kong CW; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2005 May; 16(5):457-61. PubMed ID: 15877612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy.
    Willems R; Wyse DG; Gillis AM;
    J Cardiovasc Electrophysiol; 2003 Dec; 14(12):1296-301. PubMed ID: 14678104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing.
    Saksena S; Prakash A; Hill M; Krol RB; Munsif AN; Mathew PP; Mehra R
    J Am Coll Cardiol; 1996 Sep; 28(3):687-94. PubMed ID: 8772757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of AAIR versus DDDR pacing for patients with sinus node dysfunction: a long-term follow-up study.
    Mutagaywa RK; Tumaini B; Chin A
    Cardiovasc J Afr; 2021 Jan-Feb 23; 32(1):17-20. PubMed ID: 32946543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation.
    Gillis AM; Wyse DG; Connolly SJ; Dubuc M; Philippon F; Yee R; Lacombe P; Rose MS; Kerr CD
    Circulation; 1999 May; 99(19):2553-8. PubMed ID: 10330387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L;
    Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation.
    Szili-Torok T; Kimman GP; Theuns D; Poldermans D; Roelandt JR; Jordaens LJ
    Europace; 2002 Jan; 4(1):61-5. PubMed ID: 11858154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of atrial fibrillation in patients with atrioventricular block after atrioventricular synchronized pacing.
    Kong CW; Yu WC; Chen SA; Lin YJ; Huang CY; Chung SL
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):352-7. PubMed ID: 15009862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.